Sign Out
Click on icon to see table/diagram/imageThe hard capsules should be swallowed whole with some liquid in the evening at bedtime.
They must be taken regularly.
The time required for the dissolution of gallstones is generally 6-24 months. If there is no reduction in the size of the gallstones after 12 months, the therapy should not be continued.
The success of the treatment should be checked by means of ultrasound or X-ray examination every 6 months. At the follow-up examinations, a check should be made to see whether calcification of the stones has occurred in the meantime. Should this be the case, the treatment must be ended.
For the treatment of bile reflux gastritis: 1 hard capsule of Ursofalk 250mg capsules should be swallowed whole with some liquid once daily in the evening before bedtime.
For the treatment of bile reflux gastritis Ursofalk 250mg capsules should normally be taken for 10 - 14 days. In general the duration of use depends on the course of the disease. The treating physician will decide on the duration of use in the individual case.
For the symptomatic treatment of primary biliary cirrhosis (PBC): The daily dose depends on body weight, and ranges from 3 to 7 hard capsules (14 ± 2 mg ursodeoxycholic acid per kg of body weight).
For the first 3 months of treatment, Ursofalk 250mg capsules should be taken in divided doses throughout the day. When the liver function parameters improve, the daily dose may be taken once daily in the evening. (See Table 2.)
Click on icon to see table/diagram/imageThe hard capsules should be swallowed whole with some liquid. Ursofalk 250mg capsules must be taken regularly.
The use of Ursofalk 250mg capsules in PBC may be continued indefinitely.
In patients with PBC, in rare cases the clinical symptoms may worsen at the beginning of treatment, e.g. the itching may increase. In this event, therapy should first be continued with one Ursofalk 250mg capsules daily, and the dose then gradually increased (weekly increase of the daily dose by one hard capsule) until the dose indicated in the respective dosage regimen is reached again.
FC tablet: For patients weighing less than 47 kg or patients who are unable to swallow Ursofalk 500mg film-coated tablets, Ursofalk capsules or suspension are available.
The following daily dose is recommended for the various indications: For dissolution of cholesterol gallstones: (See Table 3.)
Click on icon to see table/diagram/imageThe film-coated tablets should be swallowed whole with some liquid in the evening at bedtime. They must be taken regularly.
The time required for the dissolution of gallstones is generally 6-24 months. If there is no reduction in the size of the gallstones after 12 months, the therapy should not be continued. The success of the treatment should be checked by means of ultrasound or X-ray examination every 6 months. At the follow-up examinations, a check should be made to see whether calcification of the stones has occurred in the meantime. Should this be the case, the treatment must be ended.
For the symptomatic treatment of primary biliary cirrhosis (PBC): The daily dose depends on body weight and ranges from 1½ to 3½ film-coated tablets (14 ± 2 mg of ursodeoxycholic acid per kg of body weight).
For the first 3 months of treatment, Ursofalk 500mg film-coated tablets should be taken divided over the day. When the liver function parameters improve, the daily dose may be taken once daily in the evening. (See Table 4.)
Click on icon to see table/diagram/imageThe film-coated tablets should be swallowed whole with some liquid. They must be taken regularly.
The use of Ursofalk 500mg film-coated tablets in primary biliary cirrhosis may be continued indefinitely.
In patients with primary biliary cirrhosis, in rare cases the clinical symptoms may worsen at the beginning of treatment, e.g. the itching may increase. In this event, therapy should first be continued with half an Ursofalk 500mg film-coated tablet or one Ursofalk capsule (containing 250 mg of ursodeoxycholic acid) daily, and the dose then gradually increased (weekly increase of the daily dose by half a film-coated tablet or one Ursofalk capsule) until the dose indicated in the respective dosage regimen is reached again. In this case the dose of Ursofalk should be reduced to one Ursofalk 250mg capsule daily and then gradually increased again until the dose indicated in the respective dosage regimen is reached again.
